Gene Symbol | Gene ID | Gene Info |
---|---|---|
RUNX1
|
ENSG00000159216.14 | RUNX family transcription factor 1 |
RUNX2
|
ENSG00000124813.16 | RUNX family transcription factor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr21_36278450_36278750 | RUNX1 | 16513 | 0.288380 | 0.87 | 2.4e-03 | Click! |
chr21_36266292_36266734 | RUNX1 | 4426 | 0.347878 | 0.86 | 3.1e-03 | Click! |
chr21_36378488_36378793 | RUNX1 | 42822 | 0.212791 | 0.84 | 4.6e-03 | Click! |
chr21_36295531_36295682 | RUNX1 | 33519 | 0.237407 | 0.84 | 5.1e-03 | Click! |
chr21_36279374_36279525 | RUNX1 | 17362 | 0.286098 | 0.83 | 5.4e-03 | Click! |
chr6_45466913_45467096 | RUNX2 | 76782 | 0.102464 | 0.84 | 4.7e-03 | Click! |
chr6_45420519_45420977 | RUNX2 | 30526 | 0.187884 | 0.81 | 8.7e-03 | Click! |
chr6_45402749_45402917 | RUNX2 | 12611 | 0.215367 | 0.80 | 1.0e-02 | Click! |
chr6_45463828_45464059 | RUNX2 | 73721 | 0.107050 | 0.80 | 1.0e-02 | Click! |
chr6_45399488_45399696 | RUNX2 | 9370 | 0.220018 | 0.79 | 1.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_159474723_159475009 | 2.31 |
TAGAP |
T-cell activation RhoGTPase activating protein |
8682 |
0.2 |
chr1_150743473_150743629 | 2.23 |
CTSS |
cathepsin S |
5118 |
0.15 |
chr2_243028557_243028988 | 2.01 |
RP11-341N2.1 |
|
1836 |
0.33 |
chr5_39156051_39156436 | 1.96 |
FYB |
FYN binding protein |
46886 |
0.15 |
chr11_67181029_67181236 | 1.89 |
CARNS1 |
carnosine synthase 1 |
2017 |
0.12 |
chr8_80978227_80978671 | 1.85 |
TPD52 |
tumor protein D52 |
14561 |
0.2 |
chr3_9821453_9821979 | 1.84 |
CAMK1 |
calcium/calmodulin-dependent protein kinase I |
10040 |
0.09 |
chr6_170404847_170405519 | 1.83 |
RP11-302L19.1 |
|
72558 |
0.11 |
chr3_196370603_196370867 | 1.81 |
PIGX |
phosphatidylinositol glycan anchor biosynthesis, class X |
4089 |
0.15 |
chr12_122452097_122452248 | 1.77 |
BCL7A |
B-cell CLL/lymphoma 7A |
5156 |
0.24 |
chr7_150200142_150200645 | 1.75 |
GIMAP7 |
GTPase, IMAP family member 7 |
11525 |
0.18 |
chr2_42106310_42106729 | 1.75 |
ENSG00000223245 |
. |
8108 |
0.23 |
chr19_13211014_13211274 | 1.74 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
2537 |
0.15 |
chr6_131546387_131546540 | 1.72 |
AKAP7 |
A kinase (PRKA) anchor protein 7 |
24496 |
0.27 |
chr21_32547570_32547811 | 1.71 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
45151 |
0.19 |
chr14_88419111_88419487 | 1.70 |
GALC |
galactosylceramidase |
39883 |
0.15 |
chr17_74184327_74184668 | 1.68 |
RNF157 |
ring finger protein 157 |
21334 |
0.12 |
chr16_20855433_20855665 | 1.68 |
AC004381.6 |
Putative RNA exonuclease NEF-sp |
15703 |
0.14 |
chr9_123421630_123421856 | 1.67 |
MEGF9 |
multiple EGF-like-domains 9 |
54869 |
0.14 |
chr18_13512190_13512521 | 1.67 |
RP11-53B2.3 |
|
10532 |
0.1 |
chr6_168106937_168107158 | 1.65 |
AL009178.1 |
Uncharacterized protein; cDNA FLJ43200 fis, clone FEBRA2007793 |
89163 |
0.09 |
chr14_106691102_106691449 | 1.65 |
IGHV3-21 |
immunoglobulin heavy variable 3-21 |
928 |
0.23 |
chr3_38415816_38415967 | 1.64 |
XYLB |
xylulokinase homolog (H. influenzae) |
27545 |
0.16 |
chr3_13390098_13390249 | 1.64 |
NUP210 |
nucleoporin 210kDa |
71636 |
0.11 |
chr6_170397000_170397151 | 1.62 |
RP11-302L19.1 |
|
80666 |
0.1 |
chr17_73530969_73531279 | 1.60 |
LLGL2 |
lethal giant larvae homolog 2 (Drosophila) |
2550 |
0.17 |
chr2_198107062_198107825 | 1.59 |
ANKRD44 |
ankyrin repeat domain 44 |
44681 |
0.13 |
chr2_191329574_191329805 | 1.58 |
MFSD6 |
major facilitator superfamily domain containing 6 |
4530 |
0.21 |
chr12_125340248_125340405 | 1.57 |
SCARB1 |
scavenger receptor class B, member 1 |
8003 |
0.22 |
chr17_28650734_28650916 | 1.57 |
TMIGD1 |
transmembrane and immunoglobulin domain containing 1 |
10240 |
0.12 |
chr22_26899384_26900019 | 1.57 |
TFIP11 |
tuftelin interacting protein 11 |
2597 |
0.19 |
chr7_106767543_106767733 | 1.57 |
CTA-360L10.1 |
|
6540 |
0.23 |
chr9_92040656_92041457 | 1.55 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
7308 |
0.26 |
chr3_59925909_59926365 | 1.54 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
31446 |
0.26 |
chr1_27065921_27066122 | 1.54 |
ARID1A |
AT rich interactive domain 1A (SWI-like) |
10150 |
0.14 |
chr22_48493569_48493835 | 1.54 |
ENSG00000266508 |
. |
176474 |
0.04 |
chr1_19806357_19806811 | 1.54 |
CAPZB |
capping protein (actin filament) muscle Z-line, beta |
3995 |
0.2 |
chr5_75623548_75623935 | 1.52 |
RP11-466P24.6 |
|
16454 |
0.26 |
chr14_22573447_22573919 | 1.52 |
ENSG00000238634 |
. |
37204 |
0.21 |
chr6_170203430_170203668 | 1.52 |
RP1-266L20.9 |
|
33040 |
0.13 |
chr1_151800930_151801178 | 1.51 |
RORC |
RAR-related orphan receptor C |
2487 |
0.12 |
chr1_247486505_247486904 | 1.50 |
ZNF496 |
zinc finger protein 496 |
5843 |
0.2 |
chr20_57695724_57695939 | 1.48 |
ZNF831 |
zinc finger protein 831 |
70244 |
0.09 |
chr2_235009701_235009974 | 1.47 |
SPP2 |
secreted phosphoprotein 2, 24kDa |
50406 |
0.17 |
chr17_14098170_14098365 | 1.47 |
AC005224.2 |
|
15538 |
0.19 |
chr9_21558528_21559235 | 1.47 |
MIR31HG |
MIR31 host gene (non-protein coding) |
787 |
0.64 |
chr21_35778374_35778640 | 1.46 |
C21orf140 |
chromosome 21 open reading frame 140 |
5137 |
0.15 |
chr17_78912303_78912612 | 1.46 |
CTD-2561B21.4 |
|
3376 |
0.17 |
chr17_72635863_72636246 | 1.45 |
CD300E |
CD300e molecule |
16157 |
0.12 |
chr1_114482835_114483579 | 1.44 |
HIPK1 |
homeodomain interacting protein kinase 1 |
9857 |
0.13 |
chr1_168490958_168491381 | 1.43 |
XCL2 |
chemokine (C motif) ligand 2 |
22066 |
0.23 |
chr8_1450263_1450414 | 1.42 |
DLGAP2 |
discs, large (Drosophila) homolog-associated protein 2 |
806 |
0.77 |
chr2_39444107_39444295 | 1.42 |
CDKL4 |
cyclin-dependent kinase-like 4 |
12472 |
0.21 |
chr11_118097693_118098499 | 1.42 |
AMICA1 |
adhesion molecule, interacts with CXADR antigen 1 |
2287 |
0.23 |
chr18_3061837_3062324 | 1.41 |
ENSG00000252353 |
. |
31486 |
0.14 |
chr12_75605888_75606185 | 1.40 |
KCNC2 |
potassium voltage-gated channel, Shaw-related subfamily, member 2 |
2388 |
0.34 |
chr2_233944219_233944577 | 1.38 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
19209 |
0.18 |
chr9_102613262_102613746 | 1.38 |
NR4A3 |
nuclear receptor subfamily 4, group A, member 3 |
24495 |
0.19 |
chr11_72860781_72860988 | 1.37 |
FCHSD2 |
FCH and double SH3 domains 2 |
7578 |
0.22 |
chr13_42036238_42036522 | 1.36 |
RGCC |
regulator of cell cycle |
4685 |
0.18 |
chr17_72726639_72727007 | 1.36 |
RAB37 |
RAB37, member RAS oncogene family |
5914 |
0.11 |
chr11_36433919_36434155 | 1.36 |
PRR5L |
proline rich 5 like |
11422 |
0.18 |
chr12_15135924_15136110 | 1.36 |
PDE6H |
phosphodiesterase 6H, cGMP-specific, cone, gamma |
10061 |
0.18 |
chr14_66314193_66314576 | 1.36 |
CTD-2014B16.3 |
Uncharacterized protein |
156857 |
0.04 |
chr7_110617472_110617650 | 1.35 |
ENSG00000221279 |
. |
49187 |
0.18 |
chr3_98244489_98244640 | 1.35 |
CLDND1 |
claudin domain containing 1 |
2654 |
0.19 |
chr12_122811262_122811462 | 1.35 |
CLIP1 |
CAP-GLY domain containing linker protein 1 |
37202 |
0.15 |
chr14_59971636_59971787 | 1.34 |
JKAMP |
JNK1/MAPK8-associated membrane protein |
19922 |
0.17 |
chr12_6566343_6566774 | 1.34 |
TAPBPL |
TAP binding protein-like |
5308 |
0.1 |
chr19_8776883_8777166 | 1.33 |
ACTL9 |
actin-like 9 |
32148 |
0.15 |
chr1_161157104_161157573 | 1.33 |
B4GALT3 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 |
10051 |
0.06 |
chr21_34304286_34304477 | 1.33 |
AP000281.2 |
|
82137 |
0.07 |
chr1_11287579_11287730 | 1.33 |
ENSG00000207451 |
. |
1343 |
0.37 |
chr14_91831854_91832288 | 1.32 |
ENSG00000265856 |
. |
32014 |
0.17 |
chr12_50157909_50158281 | 1.32 |
TMBIM6 |
transmembrane BAX inhibitor motif containing 6 |
11348 |
0.16 |
chr14_89790943_89791116 | 1.31 |
RP11-356K23.1 |
|
25600 |
0.17 |
chr12_121661223_121661628 | 1.31 |
P2RX4 |
purinergic receptor P2X, ligand-gated ion channel, 4 |
13457 |
0.17 |
chr12_89600531_89600734 | 1.31 |
ENSG00000238302 |
. |
75430 |
0.12 |
chr11_68295964_68296242 | 1.30 |
PPP6R3 |
protein phosphatase 6, regulatory subunit 3 |
6776 |
0.19 |
chr7_3156856_3157022 | 1.30 |
AC091801.1 |
LOC392621; Uncharacterized protein |
40949 |
0.17 |
chr10_11188367_11188636 | 1.30 |
CELF2 |
CUGBP, Elav-like family member 2 |
18492 |
0.19 |
chr7_39576611_39576762 | 1.30 |
AC011290.4 |
|
29152 |
0.17 |
chr6_36922025_36922176 | 1.29 |
PI16 |
peptidase inhibitor 16 |
109 |
0.96 |
chr8_27227963_27228273 | 1.29 |
PTK2B |
protein tyrosine kinase 2 beta |
10050 |
0.23 |
chr17_78641311_78641681 | 1.29 |
RPTOR |
regulatory associated protein of MTOR, complex 1 |
122228 |
0.05 |
chr15_63786711_63786862 | 1.28 |
USP3 |
ubiquitin specific peptidase 3 |
10007 |
0.24 |
chr18_43785495_43785717 | 1.28 |
C18orf25 |
chromosome 18 open reading frame 25 |
31606 |
0.18 |
chr1_167571301_167571550 | 1.28 |
RCSD1 |
RCSD domain containing 1 |
27905 |
0.16 |
chr12_12402241_12402491 | 1.28 |
LRP6 |
low density lipoprotein receptor-related protein 6 |
17337 |
0.17 |
chr10_7301599_7302058 | 1.27 |
SFMBT2 |
Scm-like with four mbt domains 2 |
148879 |
0.05 |
chr3_171010915_171011188 | 1.27 |
TNIK |
TRAF2 and NCK interacting kinase |
67551 |
0.13 |
chr4_129783571_129783764 | 1.27 |
JADE1 |
jade family PHD finger 1 |
31079 |
0.24 |
chr1_112018428_112019095 | 1.27 |
C1orf162 |
chromosome 1 open reading frame 162 |
2270 |
0.16 |
chr20_20661953_20662120 | 1.27 |
RALGAPA2 |
Ral GTPase activating protein, alpha subunit 2 (catalytic) |
31095 |
0.22 |
chr2_199237056_199237207 | 1.27 |
ENSG00000252511 |
. |
194322 |
0.03 |
chr6_22155757_22155908 | 1.26 |
ENSG00000222515 |
. |
70059 |
0.13 |
chr8_134072072_134072223 | 1.26 |
SLA |
Src-like-adaptor |
456 |
0.87 |
chr16_89023342_89023579 | 1.26 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
723 |
0.59 |
chr4_16125042_16125292 | 1.25 |
PROM1 |
prominin 1 |
39166 |
0.15 |
chr14_91698344_91698868 | 1.25 |
CTD-2547L24.3 |
HCG1816139; Uncharacterized protein |
10497 |
0.16 |
chr6_154543356_154543679 | 1.25 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
24473 |
0.27 |
chr6_119637164_119637353 | 1.25 |
ENSG00000200732 |
. |
11188 |
0.25 |
chr20_62199024_62199397 | 1.25 |
HELZ2 |
helicase with zinc finger 2, transcriptional coactivator |
217 |
0.87 |
chr8_66894362_66894559 | 1.25 |
DNAJC5B |
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
39335 |
0.2 |
chr10_131969566_131969912 | 1.24 |
GLRX3 |
glutaredoxin 3 |
35076 |
0.24 |
chr20_57829219_57829466 | 1.24 |
EDN3 |
endothelin 3 |
46140 |
0.15 |
chr9_95475071_95475244 | 1.24 |
IPPK |
inositol 1,3,4,5,6-pentakisphosphate 2-kinase |
42610 |
0.13 |
chr12_4007329_4007480 | 1.24 |
RP11-664D1.1 |
|
815 |
0.7 |
chr7_27940947_27941226 | 1.24 |
ENSG00000265382 |
. |
20980 |
0.23 |
chr6_5519301_5519541 | 1.24 |
RP1-232P20.1 |
|
61113 |
0.14 |
chr10_7359930_7360081 | 1.24 |
SFMBT2 |
Scm-like with four mbt domains 2 |
90702 |
0.1 |
chr16_57577461_57577758 | 1.24 |
GPR114 |
G protein-coupled receptor 114 |
1008 |
0.47 |
chr2_15319208_15319359 | 1.24 |
NBAS |
neuroblastoma amplified sequence |
11238 |
0.32 |
chr11_72204731_72205079 | 1.23 |
CLPB |
ClpB caseinolytic peptidase B homolog (E. coli) |
59213 |
0.09 |
chr11_95453532_95453869 | 1.23 |
FAM76B |
family with sequence similarity 76, member B |
66269 |
0.12 |
chr16_89164617_89164927 | 1.23 |
ACSF3 |
acyl-CoA synthetase family member 3 |
3988 |
0.2 |
chr10_114741557_114741755 | 1.23 |
RP11-57H14.2 |
|
30022 |
0.19 |
chr10_80807558_80807756 | 1.23 |
ZMIZ1-AS1 |
ZMIZ1 antisense RNA 1 |
19568 |
0.23 |
chr5_150531228_150531691 | 1.23 |
ANXA6 |
annexin A6 |
419 |
0.86 |
chr14_61099431_61099723 | 1.23 |
SIX1 |
SIX homeobox 1 |
16603 |
0.19 |
chr4_37586119_37586320 | 1.22 |
C4orf19 |
chromosome 4 open reading frame 19 |
364 |
0.89 |
chr4_71544174_71544410 | 1.22 |
IGJ |
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
3242 |
0.15 |
chr7_37461432_37461682 | 1.22 |
ENSG00000200113 |
. |
2326 |
0.3 |
chr15_86078263_86078627 | 1.22 |
AKAP13 |
A kinase (PRKA) anchor protein 13 |
8826 |
0.21 |
chr1_207972484_207972635 | 1.21 |
ENSG00000203709 |
. |
2725 |
0.33 |
chr1_111184521_111184781 | 1.21 |
KCNA2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
10555 |
0.17 |
chr6_135449766_135450097 | 1.21 |
HBS1L |
HBS1-like (S. cerevisiae) |
25737 |
0.18 |
chr16_79485157_79485308 | 1.21 |
MAF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
148567 |
0.04 |
chr22_39296706_39296951 | 1.21 |
CBX6 |
chromobox homolog 6 |
28509 |
0.12 |
chr8_143923269_143923420 | 1.20 |
RP11-706C16.5 |
|
6988 |
0.13 |
chr16_57636080_57636317 | 1.20 |
GPR56 |
G protein-coupled receptor 56 |
8366 |
0.15 |
chr4_124528065_124528489 | 1.20 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
207154 |
0.03 |
chr12_19952865_19953078 | 1.20 |
ENSG00000200885 |
. |
75602 |
0.12 |
chr3_4537749_4538010 | 1.19 |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
2645 |
0.27 |
chr4_178321302_178321541 | 1.19 |
AGA |
aspartylglucosaminidase |
39357 |
0.13 |
chr1_194195076_194195457 | 1.19 |
ENSG00000251813 |
. |
262069 |
0.02 |
chr2_64991569_64991720 | 1.19 |
ENSG00000253082 |
. |
11594 |
0.21 |
chr3_46587447_46587598 | 1.18 |
ENSG00000264306 |
. |
4525 |
0.15 |
chr1_22357681_22358413 | 1.18 |
ENSG00000201273 |
. |
20569 |
0.09 |
chr22_18596199_18596605 | 1.18 |
TUBA8 |
tubulin, alpha 8 |
2843 |
0.22 |
chr4_90208438_90208788 | 1.18 |
GPRIN3 |
GPRIN family member 3 |
20548 |
0.27 |
chr16_79452213_79452364 | 1.18 |
ENSG00000222244 |
. |
153937 |
0.04 |
chr5_98363313_98363584 | 1.18 |
ENSG00000200351 |
. |
90997 |
0.09 |
chr1_100250518_100250669 | 1.18 |
ENSG00000201491 |
. |
152 |
0.95 |
chr12_9916868_9917340 | 1.17 |
CD69 |
CD69 molecule |
3607 |
0.2 |
chr15_70150316_70150545 | 1.17 |
ENSG00000215958 |
. |
72587 |
0.12 |
chr21_48025473_48025629 | 1.17 |
S100B |
S100 calcium binding protein B |
430 |
0.85 |
chr15_29240729_29240880 | 1.17 |
APBA2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
12703 |
0.23 |
chr5_75700608_75700759 | 1.17 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
434 |
0.9 |
chr3_32161218_32161435 | 1.17 |
GPD1L |
glycerol-3-phosphate dehydrogenase 1-like |
13135 |
0.2 |
chr10_130073537_130073688 | 1.17 |
MKI67 |
marker of proliferation Ki-67 |
148963 |
0.05 |
chr5_169760742_169761397 | 1.17 |
KCNIP1 |
Kv channel interacting protein 1 |
19422 |
0.18 |
chr8_20987611_20987997 | 1.17 |
ENSG00000215945 |
. |
25838 |
0.28 |
chr3_46390356_46390605 | 1.17 |
CCR2 |
chemokine (C-C motif) receptor 2 |
4745 |
0.2 |
chr3_140955174_140955431 | 1.17 |
ACPL2 |
acid phosphatase-like 2 |
4584 |
0.3 |
chr18_52480252_52480479 | 1.17 |
RAB27B |
RAB27B, member RAS oncogene family |
15065 |
0.27 |
chr20_16689773_16689924 | 1.16 |
SNRPB2 |
small nuclear ribonucleoprotein polypeptide B |
20758 |
0.17 |
chr4_140446686_140447128 | 1.16 |
SETD7 |
SET domain containing (lysine methyltransferase) 7 |
30455 |
0.14 |
chr5_169693981_169694136 | 1.16 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
242 |
0.94 |
chr10_73490083_73490360 | 1.16 |
C10orf105 |
chromosome 10 open reading frame 105 |
7360 |
0.22 |
chr16_57611874_57612218 | 1.16 |
GPR56 |
G protein-coupled receptor 56 |
32518 |
0.11 |
chr22_40353121_40353295 | 1.16 |
RP3-370M22.8 |
|
3193 |
0.22 |
chr6_429884_430035 | 1.16 |
IRF4 |
interferon regulatory factor 4 |
38220 |
0.2 |
chr20_39796575_39796726 | 1.15 |
RP1-1J6.2 |
|
30007 |
0.16 |
chr11_67346786_67347134 | 1.15 |
GSTP1 |
glutathione S-transferase pi 1 |
4106 |
0.11 |
chr17_19209954_19210343 | 1.15 |
EPN2-AS1 |
EPN2 antisense RNA 1 |
574 |
0.64 |
chr3_134093018_134093411 | 1.15 |
AMOTL2 |
angiomotin like 2 |
73 |
0.98 |
chr2_47205897_47206474 | 1.15 |
RP11-15I20.1 |
|
22158 |
0.15 |
chr22_42683452_42683882 | 1.15 |
TCF20 |
transcription factor 20 (AR1) |
55955 |
0.11 |
chr6_43299390_43299611 | 1.15 |
ZNF318 |
zinc finger protein 318 |
11074 |
0.14 |
chr7_50353056_50353247 | 1.15 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
4833 |
0.32 |
chr15_86245685_86246263 | 1.15 |
RP11-815J21.1 |
|
1634 |
0.25 |
chr21_32815964_32816115 | 1.15 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
99445 |
0.08 |
chr9_237130_237418 | 1.15 |
C9orf66 |
chromosome 9 open reading frame 66 |
21381 |
0.16 |
chr1_206955713_206956013 | 1.15 |
IL10 |
interleukin 10 |
10024 |
0.16 |
chr15_66704536_66704708 | 1.14 |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
25467 |
0.1 |
chr19_16373423_16373611 | 1.14 |
CTD-2562J15.6 |
|
30869 |
0.12 |
chr5_158634675_158634826 | 1.14 |
RNF145 |
ring finger protein 145 |
84 |
0.96 |
chr12_94516818_94517173 | 1.14 |
PLXNC1 |
plexin C1 |
25504 |
0.2 |
chr15_44160502_44160653 | 1.14 |
ENSG00000200391 |
. |
4374 |
0.15 |
chr21_46969788_46970179 | 1.14 |
SLC19A1 |
solute carrier family 19 (folate transporter), member 1 |
5658 |
0.24 |
chr3_45721392_45721761 | 1.14 |
LIMD1-AS1 |
LIMD1 antisense RNA 1 |
8798 |
0.18 |
chr13_99930486_99930694 | 1.14 |
GPR18 |
G protein-coupled receptor 18 |
16592 |
0.18 |
chr17_53361051_53361202 | 1.14 |
RP11-515O17.2 |
|
10112 |
0.24 |
chr7_5269929_5270177 | 1.14 |
WIPI2 |
WD repeat domain, phosphoinositide interacting 2 |
16153 |
0.16 |
chr12_113740407_113740792 | 1.14 |
SLC8B1 |
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 |
4050 |
0.2 |
chr6_138297210_138297393 | 1.13 |
RP11-356I2.4 |
|
107931 |
0.06 |
chr2_135427979_135428130 | 1.13 |
TMEM163 |
transmembrane protein 163 |
48516 |
0.18 |
chr21_32754556_32754751 | 1.13 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
38059 |
0.21 |
chr22_17200946_17201203 | 1.13 |
VWFP1 |
von Willebrand factor pseudogene 1 |
15707 |
0.18 |
chr17_55484207_55484374 | 1.13 |
ENSG00000263902 |
. |
5272 |
0.29 |
chr13_60197764_60197915 | 1.13 |
ENSG00000239003 |
. |
143635 |
0.05 |
chr2_54241307_54241458 | 1.13 |
ACYP2 |
acylphosphatase 2, muscle type |
43137 |
0.15 |
chr6_114178940_114179246 | 1.13 |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
552 |
0.77 |
chr2_169482000_169482269 | 1.13 |
ENSG00000199348 |
. |
19128 |
0.22 |
chr3_186677581_186677951 | 1.12 |
ST6GAL1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
14979 |
0.21 |
chr8_134509399_134509616 | 1.12 |
ST3GAL1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
2097 |
0.47 |
chr18_42961361_42961512 | 1.12 |
RP11-309E23.2 |
|
53826 |
0.15 |
chr1_160596572_160596895 | 1.12 |
SLAMF1 |
signaling lymphocytic activation molecule family member 1 |
20078 |
0.14 |
chr17_16192185_16192704 | 1.12 |
ENSG00000221355 |
. |
7116 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.1 | 1.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.8 | 2.3 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.8 | 2.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.7 | 2.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.7 | 2.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.7 | 2.9 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.7 | 2.7 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.7 | 0.7 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
0.7 | 2.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.7 | 2.7 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.7 | 3.3 | GO:0045588 | regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) |
0.7 | 2.7 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.7 | 2.0 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.7 | 2.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.6 | 1.9 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.6 | 6.8 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.6 | 1.9 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.6 | 5.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 2.3 | GO:0045056 | transcytosis(GO:0045056) |
0.5 | 1.6 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.5 | 0.5 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.5 | 2.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 0.5 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.5 | 1.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.5 | 1.4 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.4 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.3 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.4 | 0.4 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.4 | 1.3 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.4 | 0.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.4 | 1.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 1.2 | GO:0002693 | regulation of cellular extravasation(GO:0002691) positive regulation of cellular extravasation(GO:0002693) |
0.4 | 2.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 0.4 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.4 | 2.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.4 | 0.8 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.4 | 1.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 1.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 0.4 | GO:0071436 | sodium ion export(GO:0071436) |
0.4 | 1.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 0.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 0.7 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 0.7 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.4 | 8.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 1.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.4 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.4 | 3.6 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.4 | 0.7 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.3 | 2.8 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.3 | 3.1 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.3 | 0.7 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.3 | 0.7 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.3 | 2.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 2.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 2.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.6 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.3 | 1.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.3 | 1.0 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.3 | 0.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.3 | 3.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.6 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.3 | 1.3 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 2.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 0.3 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.3 | 0.3 | GO:0007625 | grooming behavior(GO:0007625) |
0.3 | 0.9 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 0.6 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.3 | 0.6 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.3 | 1.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 0.6 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.3 | 1.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.3 | GO:0048143 | astrocyte activation(GO:0048143) |
0.3 | 0.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 3.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.3 | 0.9 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 0.9 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 0.9 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.3 | 1.2 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 1.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.3 | 0.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.3 | 0.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.3 | 0.6 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 1.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 3.7 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.3 | 0.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 2.0 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.3 | 1.7 | GO:0050860 | regulation of T cell receptor signaling pathway(GO:0050856) negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 1.4 | GO:0043368 | positive T cell selection(GO:0043368) |
0.3 | 0.3 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.3 | 1.6 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.3 | 1.6 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.3 | 2.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.3 | 0.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.3 | 0.3 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) |
0.3 | 3.1 | GO:0000303 | response to superoxide(GO:0000303) |
0.3 | 0.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 0.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 0.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 1.0 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 0.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.2 | 0.5 | GO:0001787 | natural killer cell proliferation(GO:0001787) NK T cell proliferation(GO:0001866) |
0.2 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 1.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 1.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.5 | GO:0002836 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.2 | 0.5 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.2 | 1.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 0.2 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.2 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 0.7 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.2 | 0.2 | GO:0070254 | mucus secretion(GO:0070254) |
0.2 | 0.7 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 0.9 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.7 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.2 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.2 | 0.2 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.2 | 1.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 0.5 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 0.9 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.4 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 2.6 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 2.0 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.9 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.2 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.6 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.6 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 0.6 | GO:0042269 | regulation of natural killer cell mediated immunity(GO:0002715) regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.2 | 1.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.4 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.6 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 0.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 1.3 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 0.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.2 | 0.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 0.6 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 2.4 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.2 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.0 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.2 | 0.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 1.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 0.6 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.2 | 0.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.2 | GO:0042267 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.8 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.2 | 0.8 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 8.4 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.5 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.4 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 0.7 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.5 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.2 | 0.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.5 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.7 | GO:1901985 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 0.2 | GO:0021602 | cranial nerve morphogenesis(GO:0021602) |
0.2 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.3 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 0.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.2 | 1.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.7 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.2 | 0.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 1.2 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 1.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.3 | GO:0070265 | necrotic cell death(GO:0070265) |
0.2 | 0.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 0.3 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.2 | 2.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.2 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 1.3 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 0.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.2 | 0.3 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.2 | 0.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.2 | 0.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.2 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 0.5 | GO:0097576 | vacuole fusion(GO:0097576) |
0.2 | 0.5 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.2 | 0.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 0.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.2 | 0.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 1.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.5 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.2 | 0.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.5 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.2 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.2 | 0.3 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.2 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.6 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 0.8 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.2 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 0.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.2 | 4.7 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.2 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.6 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 2.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.9 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.1 | 0.4 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.3 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.1 | 2.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.1 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.3 | GO:0060510 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.1 | 1.0 | GO:1904377 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 1.1 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.1 | 0.1 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 1.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.6 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 1.1 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 2.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) regulation of immunoglobulin secretion(GO:0051023) positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 1.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 0.8 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.4 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.3 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.1 | 0.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.3 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 0.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.1 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.7 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 1.2 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.8 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.5 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.4 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.4 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 2.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.7 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 1.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.5 | GO:0016265 | obsolete death(GO:0016265) |
0.1 | 0.5 | GO:0021561 | facial nerve development(GO:0021561) |
0.1 | 0.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 1.7 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.8 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.6 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.6 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.1 | GO:1904063 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of cation transmembrane transport(GO:1904063) |
0.1 | 0.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.5 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.1 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.1 | 3.5 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.4 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 0.5 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.6 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 1.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.1 | GO:0045416 | regulation of interleukin-8 biosynthetic process(GO:0045414) positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.1 | 0.9 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.1 | 0.6 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 2.2 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 2.3 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.6 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 0.5 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.3 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.5 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.3 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.4 | GO:0045916 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.1 | GO:0010535 | regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.1 | 0.2 | GO:0022028 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.1 | 0.3 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.1 | 1.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.3 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 1.6 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:0060296 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.2 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 1.0 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.1 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.3 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.5 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.9 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 1.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.9 | GO:0048194 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.2 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 0.2 | GO:0016198 | axon choice point recognition(GO:0016198) axon midline choice point recognition(GO:0016199) |
0.1 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.1 | 0.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.7 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 6.3 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 0.6 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.4 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.1 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.2 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.2 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 4.8 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 1.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.4 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
0.1 | 1.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.4 | GO:0072178 | nephric duct morphogenesis(GO:0072178) mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.2 | GO:0042310 | vasoconstriction(GO:0042310) |
0.1 | 0.6 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.1 | 0.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.4 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.3 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0045762 | positive regulation of cyclase activity(GO:0031281) positive regulation of adenylate cyclase activity(GO:0045762) |
0.1 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 1.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 2.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.1 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 1.9 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.3 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.1 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.4 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.1 | 0.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.8 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.5 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0060298 | regulation of sarcomere organization(GO:0060297) positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.4 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.3 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.1 | 0.8 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.1 | 0.2 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.1 | 0.7 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 0.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.3 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0055013 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.1 | 0.3 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 0.2 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.2 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.1 | 0.1 | GO:2000053 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.5 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.1 | 0.3 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 1.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.1 | 0.1 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 0.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.1 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.8 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 15.6 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.2 | GO:0031620 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.1 | 0.3 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.5 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 2.1 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.5 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.1 | 1.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.8 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.4 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.1 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.1 | 0.2 | GO:0060760 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.5 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.5 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.1 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.1 | GO:0035304 | regulation of protein dephosphorylation(GO:0035304) |
0.1 | 0.4 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 1.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.1 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:0021955 | central nervous system projection neuron axonogenesis(GO:0021952) central nervous system neuron axonogenesis(GO:0021955) |
0.1 | 0.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.4 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.2 | GO:0043506 | regulation of JUN kinase activity(GO:0043506) positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.2 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.2 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.4 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.6 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 0.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.1 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.1 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.1 | 0.1 | GO:0032615 | interleukin-12 production(GO:0032615) |
0.1 | 0.3 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.1 | GO:0015879 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 1.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.2 | GO:0043049 | otic placode formation(GO:0043049) |
0.1 | 0.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.7 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.5 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.1 | 0.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.1 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.1 | 0.1 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.1 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.5 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 1.7 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.1 | GO:0031054 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) pre-miRNA processing(GO:0031054) |
0.1 | 0.1 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.1 | 1.8 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.7 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.5 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.5 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) mitotic G2/M transition checkpoint(GO:0044818) |
0.1 | 1.6 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 2.9 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.6 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0055069 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.1 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.5 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.1 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.1 | 0.5 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.4 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.1 | 8.1 | GO:0050776 | regulation of immune response(GO:0050776) |
0.1 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.1 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.1 | 0.1 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.1 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.9 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.1 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.1 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.1 | 0.1 | GO:0021548 | pons development(GO:0021548) |
0.1 | 7.8 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.1 | 0.7 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.1 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.1 | GO:0060179 | male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.3 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.1 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.1 | 0.1 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.5 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.1 | 0.6 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.2 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.1 | GO:0042033 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) chemokine metabolic process(GO:0050755) |
0.1 | 0.2 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.1 | 0.1 | GO:0002002 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.2 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.3 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 1.6 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.8 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 5.8 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.2 | GO:0034331 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0072506 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 2.8 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 1.3 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) actin-mediated cell contraction(GO:0070252) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.2 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.0 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.5 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.0 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.0 | 0.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.5 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.1 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.0 | 1.4 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.0 | 0.0 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.2 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 1.0 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 1.7 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.5 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.0 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.6 | GO:0015749 | monosaccharide transport(GO:0015749) |
0.0 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
0.0 | 0.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.1 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.4 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 1.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.0 | 0.2 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.0 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0051324 | prophase(GO:0051324) |
0.0 | 0.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.3 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.0 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.4 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 2.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.1 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.0 | GO:0010738 | protein kinase A signaling(GO:0010737) regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 1.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.3 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.2 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.2 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 1.9 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.0 | GO:0042312 | regulation of vasodilation(GO:0042312) |
0.0 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.3 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 7.2 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.0 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.9 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.1 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.0 | 0.1 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.1 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0003097 | renal water transport(GO:0003097) |
0.0 | 0.0 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:1902583 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.0 | 0.5 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.8 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.2 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 9.1 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.0 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 2.1 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 5.9 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.0 | GO:0030104 | water homeostasis(GO:0030104) |
0.0 | 0.0 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.3 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.0 | 0.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.0 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.1 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 1.4 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.4 | GO:0051329 | mitotic interphase(GO:0051329) |
0.0 | 0.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.0 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 1.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.4 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.0 | GO:0060325 | head morphogenesis(GO:0060323) face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.0 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.0 | 0.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.0 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.0 | GO:0002443 | leukocyte mediated immunity(GO:0002443) |
0.0 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 0.6 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 3.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 0.9 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.4 | 3.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 2.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.3 | 1.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 1.9 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 0.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 1.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 0.3 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 1.0 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.7 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 2.9 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 1.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.5 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 1.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 1.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 2.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 3.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 3.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 4.1 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.6 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 1.2 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 0.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 0.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.2 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 1.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 2.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 1.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 1.0 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.7 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 3.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.3 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.6 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 6.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 1.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 17.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.3 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.4 | GO:0030312 | external encapsulating structure(GO:0030312) external encapsulating structure part(GO:0044462) |
0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.1 | GO:0060198 | clathrin-sculpted vesicle(GO:0060198) |
0.1 | 0.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.5 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.4 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 1.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 3.3 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.1 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 3.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.1 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.5 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.6 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.9 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 1.3 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.6 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 1.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 4.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.6 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.2 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 0.3 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.6 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.9 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.5 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 2.4 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 4.6 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.1 | 0.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.5 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 2.1 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.9 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.1 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.7 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.1 | 1.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.9 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.6 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) cell envelope(GO:0030313) periplasmic space(GO:0042597) |
0.1 | 0.6 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 13.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.1 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 1.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 3.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.1 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.1 | 1.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.2 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 1.8 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.4 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 2.4 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 1.9 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 0.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 1.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.0 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 3.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 3.5 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 1.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.5 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 1.9 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 28.4 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 2.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.1 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.0 | 4.3 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.9 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 91.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 35.3 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0000803 | sex chromosome(GO:0000803) |
0.0 | 1.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 0.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 5.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 33.4 | GO:0005634 | nucleus(GO:0005634) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.1 | 3.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.0 | 3.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.8 | 2.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.7 | 2.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 6.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 3.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.5 | 3.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 1.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 1.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.5 | 2.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 2.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 5.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 8.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 0.4 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.4 | 2.6 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 2.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 1.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.4 | 3.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 1.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.4 | 4.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 1.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 1.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 1.4 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 1.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 1.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 2.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 1.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 15.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 3.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 0.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 0.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 1.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 1.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 0.9 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 1.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.3 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 0.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 10.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 1.3 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 2.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.3 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 2.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 0.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 1.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 3.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 2.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 1.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 2.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.2 | 0.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 1.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.7 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 1.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 1.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 1.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 1.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.7 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 2.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 4.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 3.6 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 1.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 2.7 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 0.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 2.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.6 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 1.1 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.2 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 1.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.7 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 1.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.2 | 0.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 0.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 1.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 1.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.2 | 0.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.2 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.2 | 0.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 2.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 0.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 2.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 1.5 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 1.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.2 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 1.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 3.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.0 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.6 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.7 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.4 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 1.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 2.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 1.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.1 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 2.1 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.1 | 3.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 3.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 1.2 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.8 | GO:0070717 | poly(A) binding(GO:0008143) poly-purine tract binding(GO:0070717) |
0.1 | 0.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.2 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.5 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.2 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 1.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 1.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.4 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.3 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 1.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.2 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 1.1 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 2.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 1.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
0.1 | 0.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.7 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 3.3 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.1 | 0.2 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 1.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 1.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 2.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.6 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.7 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.4 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.2 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.3 | GO:0004340 | glucokinase activity(GO:0004340) |
0.1 | 0.6 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.1 | GO:0032356 | single guanine insertion binding(GO:0032142) oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 4.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.2 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 3.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.2 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 3.3 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 4.2 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.6 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 2.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.5 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 1.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.4 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.2 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) phosphoserine binding(GO:0050815) |
0.1 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 1.7 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.3 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.8 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.6 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.4 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 4.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.3 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.5 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.4 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.1 | 0.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.9 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 1.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 8.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 2.1 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.9 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.9 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.0 | 3.0 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 7.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.2 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 1.6 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 10.8 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 3.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 2.9 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 6.3 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.0 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 1.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 7.1 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0001159 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 9.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.6 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 3.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 1.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 1.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.8 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 10.6 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.3 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.0 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.0 | 0.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.7 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.1 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 1.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 30.7 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.1 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.6 | 8.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 4.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 3.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 10.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 17.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 15.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 10.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 7.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 3.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 0.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 7.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 3.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 4.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 1.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 0.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 4.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 5.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 2.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 2.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 5.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 2.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 3.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 2.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 1.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.9 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.8 | 2.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.6 | 16.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 11.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 2.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 0.7 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.3 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 3.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 4.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 1.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 2.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 3.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 2.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 1.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 9.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 6.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 3.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 2.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 11.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 3.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 4.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 8.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 0.4 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 1.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 4.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 2.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 3.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 1.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 0.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 7.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 3.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 2.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 1.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 0.3 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.1 | 0.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 6.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 6.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 4.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 4.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.6 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 1.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 7.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 2.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 5.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 2.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.2 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.1 | 1.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 5.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 3.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 5.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 1.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 5.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 4.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 1.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 4.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 1.7 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 3.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 3.4 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.0 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.0 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 1.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 1.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 8.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.4 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |